Records and reported status
Jul 17, 2023 FDA drug enforcement
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for midazolam in dextrose 5%, 50 mg /50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Phar... Jul 17, 2023 FDA drug enforcement
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for rocuronium, 50 mg /5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, ... Jul 17, 2023 FDA drug enforcement
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL, (80 mcg/mL), 10 mL Syringe, Rx only, CAPS, ... Jul 17, 2023 FDA drug enforcement
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for PHENYLephrine in 0.9 sodium chloride, 400 mcg /10 mL, (40 mcg/mL), 10 mL Syringe, Rx only, CAPS, ... Jul 17, 2023 FDA drug enforcement
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central Admixt... Jul 17, 2023 FDA drug enforcement
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for morphine in 0.9% Sodium Chloride, 50 mg/50 mL (1mg/mL), 50 mL Syringe, Rx only, Central Admixture... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for rocuronium50 mg/5 mL (10 mg/mL), Syringes Rx only, this drug was repackaged by CAPS Inc, 2200 Sou... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for vancomycin 1 g/250 mL added to 0.9% sodium chloride, 4 mg/mL, IV Bag, Rx only, Cental Admixture P... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for succinylcholine 200 mg/10 mL (20 mg/mL), Syringe, Rx only, this drug was repackaged by CAPS Inc, ... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for vancomycin 1.25 g/250 mL added to dextrose 5%, 5 mg/mL, IV Bag, Rx only, Central Admixture Pharma... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for dilTIAZem 125mg/125mL (1 mg/mL), added to dextrose 5%, IV Bag, RX only, Central Admixture Pharmac... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, CAPS, Inc., 2200 Sout... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for dilTIAZem 125mg/125mL (1 mg/mL), added to 0.9% sodium chloride, IV Bag, Rx Only, Central Admixtur... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for EPINEPHrine 4mg/250mL added to 0.9% sodium chloride, IV Bag, RX only, Central Admixture Pharmacy ... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for vancomycin 1.25 g/250 mL added to 0.9% Sodium Chloride, 5 mg/mL, IV Bag, Rx only, Central Admixtu... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for Cardioplegia Solution del Nido Formula, IV Bag, Total Volume = 1,052.8 mL, FOR INTRACARDIAC PERFU... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for EPINEPHrine, 2 mg added to dextrose 5% 250mL, Concentration = 8 mcg/mL, IV Bag, Rx Only, Central ... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for EPINEPHrine added to dextrose 5%, 4mg/250ml, IV Bag, Rx Only, Central Admixture Pharmacy Services... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for EPINEPHrine 8mg/250ml added to dextrose 5%, 32 mcg/mL, IV Bag, Rx Only, Central Admixture Pharmac... Jul 14, 2023 FDA drug enforcement
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II Reported terminated
Distribution: Nationwide in the USA
Official source for PHENYLephrine, 10mg/250ml added to 0.9% sodium chloride, 40mcg/mL, IV Bag, Rx Only, Central Admix...
Reasons in these listed records Lack of assurance of sterility: Lack of validation data for sanitization cycles Lack of assurance of sterility. Validation data for decontamination cycles is lacking. These examples come from this result page and are not a ranking of every recall reason.
Checking Central Admixture Pharmacy Services, Inc. Is there a recall on central admixture pharmacy services, inc. right now? This archive contains 309 records, including 3 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Where can I find older records? Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.